Description:

Cycle Dose Drug Form, GOG-0212, Form D2R Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer NCT00108745 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=E74972BD-ECF1-48B2-E034-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=E74972BD-ECF1-48B2-E034-0003BA3F9857

Keywords:
Versions (3) ▾
  1. 9/19/12
  2. 1/8/15
  3. 1/9/15
Uploaded on:

January 9, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Cycle Dose Drug Form D2R Fallopian Tube Cancer (NCT00108745)

No Instruction available.

  1. StudyEvent: Cycle Dose Drug Form, GOG-0212, Form D2R
    1. No Instruction available.
Header Module
Treatment Cycle And Modification
Cycle delayed
Cycle delayed reason
Were there any dose modifications or additions/omissions to protocol treatment (1=Yes, planned; 2 =Yes, unplanned; 3=No)
Kg
Performance status (Zubrod)
Pretreatment Hematology And Chemistry Values
g/dL
1000/uL
1000/uL
1000/uL
mg/dL
mg/dL

Similar models